What is the Issue with Ozempic?
A core complaint in current Ozempic lawsuits is that the pharmaceutical companies failed to adequately warn users that Ozempic (and other GLP-1 RAs) could cause gastroparesis (stomach paralysis), ileus (lack of movement through intestines), and intestinal pseudo-obstruction.
The first Ozempic stomach paralysis lawsuit was filed on August 2, 2023, by a woman from Louisiana regarding Ozempic’s link to gastroparesis, a serious condition where the stomach becomes paralyzed. The lawsuit is based on a “failure to warn” regarding Eli Lilly and Co., and a lack of appropriate labeling informing consumers of the risks regarding Novo Nordisk.
Even though Ozempic has shown some positive results for some users, it still has caused many to develop health conditions they were not aware the drug had a risk of causing.
Plaintiffs allege that the drug causes dangerous gastrointestinal conditions, specifically gastroparesis, which is a chronic condition. It cannot be cured; it can only be managed medically and surgically. For these patients, that means facing a lifetime of medical interventions.
START YOUR FREE, CONFIDENTIAL CASE EVALUATION TODAY.
Ozempic Semaglutide
Ozempic is a brand-name semaglutide injectable drug. Originally developed to treat patients with Type 2 diabetes, it has also been used as an off-label weight loss drug.
Other GLP-1 Receptor Agonist drugs in the same class as Ozempic include:
- Mounjaro (tirzapatide)
- Wegovy (semaglutide)
- Rybelsus (semaglutide)
These drugs produce insulin and lower blood sugar. They also release a hormone that slows down digestion and keeps food in the patient’s stomach longer. Some studies, such as one published in the Journal of the American Medical Association, have shown that semaglutides such as Ozempic increase the risk of gastroparesis and other gastrointestinal conditions.
Ozempic is an FDA-approved diabetes drug, approved in 2017 and produced by Novo Nordisk. It is a GLP-1 Receptor Agonist Analog-Type drug used to control high blood sugar in Type 2 diabetes. In 2021, the FDA approved Wegovy for long-term weight management in adults who have at least one other weight-related condition.
As with any drug, there can be side effects. Gastrointestinal (GI) events are known side effects of the GLP-1 class. However, it is the manufacturer’s responsibility to inform consumers of the risks. Lawsuits claim that Novo Nordisk, the manufacturer, failed to do this.
Questions? Contact us at (877) 284-6600, Chat Online or use our Text Us widget.
Ozempic’s Injuries
Gastroparesis (stomach paralysis) has been associated with drugs like Ozempic, Wegovy, Rebelsus, and others. Other risks include ileus (lack of movement through intestines) and intestinal pseudo-obstruction.
Gastroparesis is a chronic condition where the nerves and muscles in the stomach wall severely weaken. This weakening makes it more difficult for the stomach to transfer food to the small intestine. Results of gastroparesis include intestinal blockages or obstruction, and it often leads to nausea and diarrhea. People can experience the following symptoms:
- Persistent vomiting
- Persistent nausea
- Diarrhea
- Abdominal bloating and/or pain
- A feeling of fullness after eating just a few bites
- Acid reflux
- Changes in blood sugar levels
- Weight loss and malnutrition
February 6, 2024, Multidistrict Litigation was created which includes Ozempic and all similar drugs.
DO YOU HAVE AN OZEMPIC LAWSUIT?
Have you:
- Used Ozempic for weight loss?
- Suffered serious health issues like gastroparesis, ileus, or others?
Call today to find out if you have a case. One of our Ozempic lawyers can tell you if you qualify to file a lawsuit. Depending on where you live, you may only have a limited time to file.
Questions? Contact us at (877) 284-6600. One of our Ozempic lawyers will help you.
Our Ozempic lawyers will advocate on your behalf and handle the legal process for you, such as:
- Verifying your eligibility through a free, no-obligation review of your case.
- Gathering evidence needed to build your case.
- Filing your Ozempic lawsuit, meeting any state deadlines and statute of limitations.
- Negotiating a settlement or presenting your case in court if no settlement is reached.
There is no cure for gastroparesis, and plaintiffs are seeking compensation for loss of quality of life, past and future medical bills, and other damages.
START YOUR FREE, CONFIDENTIAL CASE EVALUATION WITH ONE OF OUR TEAM TODAY!
If you or someone you know has been diagnosed with stomach paralysis or another gastrointestinal injury related to Ozempic, contact the law offices of Nash & Franciskato at (877) 284-6600. One of our experienced staff will speak with you personally and will provide you with a free, no-obligation review of your case.
Find out if you have a case against Novo Nordisk or Eli Lilly.
START YOUR FREE CASE EVALUATION TODAY